ETC-1002 regulates immune response, leukocyte homing, and adipose tissue inflammation via LKB1-dependent activation of macrophage AMPKС. И. Филиппов(Kazan Federal University), Roger S. Newton(Esperion Therapeutics (United States))Journal of Lipid ResearchMay 25, 201310.1194/jlr.m035212Cited by 87SaveCiteExport RISWatch citationsRelated PapersAMP-activated protein kinase and ATP-citrate lyase are two distinct molecular targets for ETC-1002, a novel small molecule regulator of lipid and carbohydrate metabolism|Journal of Lipid Research|2012|234